My Cart
You have no items in your shopping cart.
Background
The human KCNC4 gene encodes the pore-forming subunit of Kv3.4, a voltage-gated potassium channel expressed in the CNS, parathryroid gland, skeletal muscle, and pancreas. Kv3.4 channel expression is upregulated in Alzheimer's disease and presents potential therapeutic target in Alzheimer’s disease.
| General Info | |
| Product Description | Human Kv3.4 potassium ion channel-expressing, stable replicating cell line (HEK). |
|---|---|
| Target Type | Ion Channel |
| Product Type | Replicating Cell Line |
| Family | Potassium, Voltage-Gated |
| Sub-Type | Kv3.4 |
| Class | Voltage-gated potassium channel |
| Therapeutic Area | neurodegeneration & stroke |
| Related Services | Large-scale Cryopreservation |
| Gene Name | KCNC4 |
| Validated Assay/Platform | IonWorks Quattro™, PatchXpress® |
| References | Gutman GA, et al. 2005. Pharmacol Rev. 57:473-508. International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels. |
| Host cell | HEK293 |
| Mycoplasma Status | Negative (MycoAlert Kit) |
| Storage & Packaging | |
| Packaging | Cryopreserved cells, 1-2x106 cells |
| Storage Recommendation | liquid nitrogen |
| Quantity | 1-2 million cells |
| Product Documentation | |
| Specification Sheet |  Download PDF Document |
